6 Amendments of Nicola CAPUTO related to 2017/0328(COD)
Amendment 13 #
Draft legislative resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Regrets that the procedure for the selection of the new EMA headquarters was concluded by drawing lots, despite the importance of this decision; considers that a decision of such vital importance for Europe cannot be left to chance and that the European Parliament, as co- legislator, must be involved in the selection of the new EMA headquarters;
Amendment 16 #
Draft legislative resolution
Paragraph 2 b (new)
Paragraph 2 b (new)
2b. Considers that the details of the two-stage transfer process, entailing operational restrictions during the transition period, were unclear and lacking transparency and that such obfuscation adversely affected the position of the other Member States during consideration of their applications and the procedure for selecting the new EMA headquarters;
Amendment 30 #
Draft legislative resolution
Paragraph 4 a (new)
Paragraph 4 a (new)
4a. Considers that the two-stage transfer procedure will prolong the period during which the EMA will be unable to operate to capacity; urges, therefore, that the decision regarding the location of the EMA be reconsidered in the light of the delays occurring in Amsterdam, which are undermining the right to health of our citizens, infringing the principle of continuity and incurring additional costs for the European budget;
Amendment 41 #
Proposal for a regulation
Recital 1 a (new)
Recital 1 a (new)
(1a) However, that decision must take into account the need to find a suitable headquarters by March 2019, and no suitable premises are yet available. Furthermore, the building chosen must be immediately fit for purpose to avoid inconvenience, additional costs and repercussions regarding citizens' right to health;
Amendment 44 #
Proposal for a regulation
Article 1 – paragraph 1
Article 1 – paragraph 1
Regulation (EC) No 726/2004
Article 71a
Article 71a
The seat of the Agency shall have its seat in Amsterdam, the Netherlands. be located in a city of a European Union Member State on the basis of absolute assurance that: - it meets, without any exception or limitation, as from January 2019, all requirements, conditions and criteria necessary to ensure that the Agency can function effectively; - it ensures the full and immediate operational continuity of the Agency’s activities, which are highly important to society and of great scientific value. The Agency's remit shall relate to what is recognised as a fundamental right of European citizens to health protection. Its headquarters shall be selected under the ordinary legislative procedure pursuant to Articles 114 and 168(4)(b) TFEU.
Amendment 46 #
Proposal for a regulation
Article 1 – paragraph 1
Article 1 – paragraph 1
Regulation (EC) No 726/2004
Article 71a
Article 71a
The Agency shall have its seat in Amsterdam, the NetherlandsMilan, Italy.